Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast detoxification of opioid addiction in patients with opioid-induced hyperalgesia
2009-015866-71Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of naloxone in opioid-induced hyperalgesia (OIH) and opioid use disorder (OUD), sponsored by Karolinska University Hospital. Primary endpoints: EQ-5D scale, VAS scale and 2 more. Started Nov 2009; status: active.
02
Drugs
naloxone
03
Conditions
opioid-induced hyperalgesia (OIH)opioid use disorder (OUD)
Beyond the preview
Go deeper on 2009-015866-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015866-71.